Who owns Elanco?
Elanco Animal Health Incorporated is an American pharmaceutical company that produces medicines and vaccinations for pets and livestock. Elanco employs more than 3,000 people worldwide, with offices in more than 40 countries, and is a division of Eli Lilly and Company, a leading global pharmaceutical corporation. Who owns Elanco? Elanco is a global, innovation-driven company…
Elanco Animal Health Incorporated is an American pharmaceutical company that produces medicines and vaccinations for pets and livestock. Elanco employs more than 3,000 people worldwide, with offices in more than 40 countries, and is a division of Eli Lilly and Company, a leading global pharmaceutical corporation.
Who owns Elanco?
Elanco is a global, innovation-driven company that develops and markets products and services to improve animal health and protein production in more than 75 countries. The company can trace its roots back to 1953 when Eli Lilly introduced their first antibiotic aimed at veterinary usage with the new plant and animal sciences research being combined into Lilly’s Agro-Industrial division led by George Barnes.
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work.
On December 3, 2020, Elanco announced plans to build a new global headquarters in Indianapolis at the site of the former GM stamping plant, which is located across the White River from the downtown area. The business plans to break ground on the new headquarters in the first half of 2021.
